Fotona purchases dental division of A.R.C. LASER

Fotona has previously been a distributor of the XLASE 1064 nm dental lasers in the United States.

The newly acquired Fox technology with 455, 810, 980 and 1064 nm wavelengths represents a line of high-performance, powerful diode lasers that are small, lightweight and battery operated for maximum convenience. These systems perform a wide range of surgical, periodontal, photothermal therapy (PTT) and low level laser therapy (LLLT) procedures.

EmunDo is a PTT system, used in conjunction with the Fox lasers, for less invasive treatment of periodontitis without antibiotics. Learn more here: https://www.fotona.com/en/products/6236/xpulse-r-line/.

Jeff Jones, president of Fotona, said: “Fotona has long been a world leader and innovator in the dental laser industry. Adding the Fox III and Fox IV lasers systems and the EmunDo Therapy system to our line of LightWalkerTM and SkyPulse lasers will expand our dental product offering. Fotona dental lasers systems provide general dentists, periodontists, endodontists, pediatric dentists and hygienists the ability to provide their patients with advanced and less invasive treatment options. Fotona procedures include no-shot cavity preps, soft-tissue surgical procedures, treatments for periodontal disease, endodontic treatments, LLLT pain relief, laser-assisted hygiene, snoring and sleep treatments, facial aesthetic procedures and much more.”

Angela Thyzel, A.R.C. CEO, added: “Selling our dental division to Fotona will allow our company to provide more focus on our core, industry leading products for ophthalmology, otolaryngology and veterinary applications. A.R.C. has known and worked with the senior executives at Fotona for many years and respect their expertise in dentistry and are confident they will continue to grow the customer base for these advanced products in dentistry and other areas.”

A.R.C. Laser GmbH was founded in 1996, with the goals of developing and producing laser-based solutions for gentle and effective surgeries and treatments, ranging from highly complex ophthalmic systems (including slit lamps and microscopes), ENT and many other medical products. Because of its innovations, A.R.C. has been a pioneer and leader worldwide.

During the COVID-19 challenge, Fotona took advantage of the opportunity to do more for its customers and employees, expanding its offering, doing more research, product development and becoming even stronger for tomorrow. Fotona made another acquisition during this period, which it is excited to announce in the very near future.

(Source: Fotona)

Tags: